Then we reviewed existing early diagnostic markers commonly used for AD: CSF biomarkers including Aβ42, T‐tau, and P‐tau; PET imaging of amyloid and tau; Pittsburgh compound‐B; and FDG PET. This evidence concerns the gene MAPT and Alzheimer disease.